Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes.

Area of Science:

• Neuroscience
• Genomics
• Immunology

Background:

• Neurological diseases like multiple sclerosis (MS) exhibit complex gene expression changes across the central nervous system (CNS).
• Understanding cell-type and region-specific alterations is crucial due to cellular heterogeneity and disease-induced compositional changes.
• MS is a multifocal disease, necessitating investigations that account for regional variations.

Purpose of the Study:

• To investigate region-specific gene expression changes in astrocytes during experimental autoimmune encephalomyelitis (EAE), a model for MS.
• To identify potential therapeutic targets by analyzing astrocyte transcriptomics across different neuroanatomic regions.

Main Methods:

• Utilized a cell-specific and region-specific transcriptomics approach.
• Employed RiboTag technology to isolate astrocyte-specific RNAs from various CNS regions (spinal cord, cerebellum, cerebral cortex, hippocampus).
• Performed sequencing and bioinformatics analyses to identify differential gene expression patterns.

Main Results:

• EAE induced distinct gene expression changes in astrocytes depending on the neuroanatomic region.
• In spinal cord astrocytes during chronic EAE, decreased cholesterol synthesis gene expression and increased immune pathway gene expression were observed.
• Decreased cholesterol synthesis gene expression was also noted in astrocytes from the optic nerve (EAE) and optic chiasm (MS).

Conclusions:

• Astrocyte gene expression is heterogeneous across CNS regions in the context of EAE.
• Astrocytes play a role in cholesterol synthesis and immune responses within the CNS during demyelinating disease.
• Cell- and region-specific transcriptomics offers a powerful approach to uncover novel therapeutic targets for multifocal neurological diseases like MS.